NASDAQ:AZYO
Delisted
Aziyo Biologics Inc. Stock News
$1.49
+0 (+0%)
At Close: Dec 05, 2023
Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences
09:05pm, Monday, 15'th Nov 2021 Intrado Digital Media
SILVER SPRING, Md., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the company will participate in two upcoming virtual investor conferences.
Cantor Fitzgerald Reiterates Overweight Rating for Aziyo Biologics (NASDAQ:AZYO)
07:52am, Sunday, 14'th Nov 2021 Transcript Daily
Cantor Fitzgerald reaffirmed their overweight rating on shares of Aziyo Biologics (NASDAQ:AZYO) in a research note published on Thursday morning, Zacks.com reports. Several other brokerages also recently commented on AZYO. Zacks Investment Research downgraded shares of Aziyo Biologics from a hold rating to a sell rating in a research report on Friday, October 29th. Piper []
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q3 2021 Results - Earnings Call Transcript
08:47pm, Tuesday, 09'th Nov 2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q3 2021 Results - Earnings Call Transcript
Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Misses Revenue Estimates
07:49pm, Tuesday, 09'th Nov 2021
Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of -32.79% and -0.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the st
SILVER SPRING, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated p
Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference
04:05pm, Wednesday, 15'th Sep 2021
SILVER SPRING, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Aziyo Biologics Appoints Peter G. Edwards as General Counsel
04:05pm, Tuesday, 31'st Aug 2021
SILVER SPRING, Md., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated p
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q2 2021 Results - Earnings Call Transcript
09:13pm, Monday, 09'th Aug 2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q2 2021 Results - Earnings Call Transcript
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q1 2021 Results - Earnings Call Transcript
12:27am, Monday, 10'th May 2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q1 2021 Results - Earnings Call Transcript
Aziyo Biologics Reports First Quarter 2021 Financial Results and Increases 2021 Revenue Guidance
04:05pm, Tuesday, 04'th May 2021
SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pr
Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit
04:05pm, Monday, 26'th Apr 2021
SILVER SPRING, Md., April 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q4 2020 Results - Earnings Call Transcript
10:44pm, Monday, 01'st Mar 2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q4 2020 Results - Earnings Call Transcript
Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results
04:05pm, Monday, 01'st Mar 2021
SILVER SPRING, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Aziyo Biologics to Participate in the Cowen 41st Annual Health Care Conference
04:05pm, Thursday, 18'th Feb 2021
SILVER SPRING, Md., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated p
Aziyo Biologics Announces First Patient Enrolled in HEAL Study
04:05pm, Wednesday, 17'th Feb 2021
SILVER SPRING, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated p
